The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sodium Valproate-Global Market Insights and Sales Trends 2025
Synopsis
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
The global Sodium Valproate market size is expected to reach US$ 252.5 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Sodium Valproate in various end use industries. The expanding demands from the Epilepsy, Migraines and Others,, are propelling Sodium Valproate market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sodium Valproate market, driven by demand from China, the second largest economy with some signs of stabilising, the Sodium Valproate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sodium Valproate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sodium Valproate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sodium Valproate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sodium Valproate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sodium Valproate covered in this report include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt and Zentiva, etc.
The global Sodium Valproate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Global Sodium Valproate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sodium Valproate market, Segment by Type:
Injection
Tablet
Liquid
Global Sodium Valproate market, by Application
Epilepsy
Migraines
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sodium Valproate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sodium Valproate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
The global Sodium Valproate market size is expected to reach US$ 252.5 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Sodium Valproate in various end use industries. The expanding demands from the Epilepsy, Migraines and Others,, are propelling Sodium Valproate market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sodium Valproate market, driven by demand from China, the second largest economy with some signs of stabilising, the Sodium Valproate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sodium Valproate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sodium Valproate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sodium Valproate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sodium Valproate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sodium Valproate covered in this report include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt and Zentiva, etc.
The global Sodium Valproate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Global Sodium Valproate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sodium Valproate market, Segment by Type:
Injection
Tablet
Liquid
Global Sodium Valproate market, by Application
Epilepsy
Migraines
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sodium Valproate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sodium Valproate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Sodium Valproate Market Overview
1.1 Sodium Valproate Product Overview
1.2 Sodium Valproate Market Segment by Type
1.2.1 Injection
1.2.2 Tablet
1.2.3 Liquid
1.3 Global Sodium Valproate Market Size by Type
1.3.1 Global Sodium Valproate Market Size Overview by Type (2018-2029)
1.3.2 Global Sodium Valproate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sodium Valproate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sodium Valproate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sodium Valproate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sodium Valproate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sodium Valproate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sodium Valproate Sales Breakdown by Type (2018-2023)
2 Global Sodium Valproate Market Competition by Company
2.1 Global Top Players by Sodium Valproate Sales (2018-2023)
2.2 Global Top Players by Sodium Valproate Revenue (2018-2023)
2.3 Global Top Players by Sodium Valproate Price (2018-2023)
2.4 Global Top Manufacturers Sodium Valproate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sodium Valproate Market Competitive Situation and Trends
2.5.1 Sodium Valproate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sodium Valproate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sodium Valproate as of 2022)
2.7 Date of Key Manufacturers Enter into Sodium Valproate Market
2.8 Key Manufacturers Sodium Valproate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sodium Valproate Status and Outlook by Region
3.1 Global Sodium Valproate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sodium Valproate Historic Market Size by Region
3.2.1 Global Sodium Valproate Sales in Volume by Region (2018-2023)
3.2.2 Global Sodium Valproate Sales in Value by Region (2018-2023)
3.2.3 Global Sodium Valproate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sodium Valproate Forecasted Market Size by Region
3.3.1 Global Sodium Valproate Sales in Volume by Region (2024-2029)
3.3.2 Global Sodium Valproate Sales in Value by Region (2024-2029)
3.3.3 Global Sodium Valproate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sodium Valproate by Application
4.1 Sodium Valproate Market Segment by Application
4.1.1 Epilepsy
4.1.2 Migraines
4.1.3 Others
4.2 Global Sodium Valproate Market Size by Application
4.2.1 Global Sodium Valproate Market Size Overview by Application (2018-2029)
4.2.2 Global Sodium Valproate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sodium Valproate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sodium Valproate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sodium Valproate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sodium Valproate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sodium Valproate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sodium Valproate Sales Breakdown by Application (2018-2023)
5 North America Sodium Valproate by Country
5.1 North America Sodium Valproate Historic Market Size by Country
5.1.1 North America Sodium Valproate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sodium Valproate Sales in Volume by Country (2018-2023)
5.1.3 North America Sodium Valproate Sales in Value by Country (2018-2023)
5.2 North America Sodium Valproate Forecasted Market Size by Country
5.2.1 North America Sodium Valproate Sales in Volume by Country (2024-2029)
5.2.2 North America Sodium Valproate Sales in Value by Country (2024-2029)
6 Europe Sodium Valproate by Country
6.1 Europe Sodium Valproate Historic Market Size by Country
6.1.1 Europe Sodium Valproate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sodium Valproate Sales in Volume by Country (2018-2023)
6.1.3 Europe Sodium Valproate Sales in Value by Country (2018-2023)
6.2 Europe Sodium Valproate Forecasted Market Size by Country
6.2.1 Europe Sodium Valproate Sales in Volume by Country (2024-2029)
6.2.2 Europe Sodium Valproate Sales in Value by Country (2024-2029)
7 Asia-Pacific Sodium Valproate by Region
7.1 Asia-Pacific Sodium Valproate Historic Market Size by Region
7.1.1 Asia-Pacific Sodium Valproate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sodium Valproate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sodium Valproate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sodium Valproate Forecasted Market Size by Region
7.2.1 Asia-Pacific Sodium Valproate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sodium Valproate Sales in Value by Region (2024-2029)
8 Latin America Sodium Valproate by Country
8.1 Latin America Sodium Valproate Historic Market Size by Country
8.1.1 Latin America Sodium Valproate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sodium Valproate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sodium Valproate Sales in Value by Country (2018-2023)
8.2 Latin America Sodium Valproate Forecasted Market Size by Country
8.2.1 Latin America Sodium Valproate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sodium Valproate Sales in Value by Country (2024-2029)
9 Middle East and Africa Sodium Valproate by Country
9.1 Middle East and Africa Sodium Valproate Historic Market Size by Country
9.1.1 Middle East and Africa Sodium Valproate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sodium Valproate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sodium Valproate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sodium Valproate Forecasted Market Size by Country
9.2.1 Middle East and Africa Sodium Valproate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sodium Valproate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Sodium Valproate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Sodium Valproate Products Offered
10.1.5 Sanofi Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Information
10.2.2 AbbVie Introduction and Business Overview
10.2.3 AbbVie Sodium Valproate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AbbVie Sodium Valproate Products Offered
10.2.5 AbbVie Recent Development
10.3 Athenex
10.3.1 Athenex Company Information
10.3.2 Athenex Introduction and Business Overview
10.3.3 Athenex Sodium Valproate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Athenex Sodium Valproate Products Offered
10.3.5 Athenex Recent Development
10.4 Fresenius Kabi
10.4.1 Fresenius Kabi Company Information
10.4.2 Fresenius Kabi Introduction and Business Overview
10.4.3 Fresenius Kabi Sodium Valproate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Fresenius Kabi Sodium Valproate Products Offered
10.4.5 Fresenius Kabi Recent Development
10.5 Hikma Farmaceutica
10.5.1 Hikma Farmaceutica Company Information
10.5.2 Hikma Farmaceutica Introduction and Business Overview
10.5.3 Hikma Farmaceutica Sodium Valproate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hikma Farmaceutica Sodium Valproate Products Offered
10.5.5 Hikma Farmaceutica Recent Development
10.6 Desitin Pharmaceuticals
10.6.1 Desitin Pharmaceuticals Company Information
10.6.2 Desitin Pharmaceuticals Introduction and Business Overview
10.6.3 Desitin Pharmaceuticals Sodium Valproate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Desitin Pharmaceuticals Sodium Valproate Products Offered
10.6.5 Desitin Pharmaceuticals Recent Development
10.7 Wockhardt
10.7.1 Wockhardt Company Information
10.7.2 Wockhardt Introduction and Business Overview
10.7.3 Wockhardt Sodium Valproate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Wockhardt Sodium Valproate Products Offered
10.7.5 Wockhardt Recent Development
10.8 Zentiva
10.8.1 Zentiva Company Information
10.8.2 Zentiva Introduction and Business Overview
10.8.3 Zentiva Sodium Valproate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Zentiva Sodium Valproate Products Offered
10.8.5 Zentiva Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sodium Valproate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sodium Valproate Industrial Chain Analysis
11.4 Sodium Valproate Market Dynamics
11.4.1 Sodium Valproate Industry Trends
11.4.2 Sodium Valproate Market Drivers
11.4.3 Sodium Valproate Market Challenges
11.4.4 Sodium Valproate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sodium Valproate Distributors
12.3 Sodium Valproate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
